We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Guidance on Special Controls for Cystic Fibrosis Assays
FDA Issues Guidance on Special Controls for Cystic Fibrosis Assays
January 12, 2007
Firms should establish special controls to ensure the safety and effectiveness of quality control (QC) materials for cystic fibrosis nucleic acid assays, the FDA said in guidance published Jan. 10.